Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.

To put this in further perspective, the low percentage of patients (2.3–3.5%) in whom a chemotherapy indication is missed will yield an even much lower and probably not significant difference in regional recurrence and overall survival.

also in 240 other papers